DGX vs RPAY · P/E 22, rev $5.94B vs rev $181.5M
Quest Diagnostics Incorporated (DGX) versus Repay Holdings Corp (RPAY) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Repay Holdings Corp (RPAY) is a software - infrastructure company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported RPAY revenue for 2026-06-30 was $181.5M. Net income was -$20.9M. RPAY currently screens at market cap $292.4M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. RPAY currently screens at market cap $292.4M.
Not investment advice. Open the DGX and RPAY stock pages for the full models.
Not investment advice.